Literature DB >> 17090886

The treatment of ocular tuberculosis: a survey of published literature.

Salil Mehta1.   

Abstract

With an expanding awareness of ocular tuberculosis, ophthalmologists are increasingly required to participate in the care of these patients. We conducted a survey of published ophthalmic literature to identify whether the regimens of antitubercular medications prescribed conform to current guidelines. A Medline search for publications (1995-2005) was done and the data were systematically analyzed with respect to demographic features, clinical findings and the antitubercular therapy prescribed. Of the 34 papers (82 patients) available, 33 papers described the prescribed antitubercular therapy. Eighteen papers (54.5%, 46 patients) conformed to guidelines versus 15 papers (45.4%, 32 patients) did not, suggesting that a large proportion of papers do not conform to current guidelines. Wider dissemination of therapeutic guidelines is necessary to encourage rational therapy and minimize therapeutic failures, drug resistance or relapse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090886     DOI: 10.4103/0301-4738.27959

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  3 in total

1.  Clinical spectrum of tuberculous optic neuropathy.

Authors:  Ellen J Davis; Sivakumar R Rathinam; Annabelle A Okada; Sharon L Tow; Harry Petrushkin; Elizabeth M Graham; Soon-Phaik Chee; Yan Guex-Crosier; Eva Jakob; Ilknur Tugal-Tutkun; Emmett T Cunningham; Jacqueline A Leavitt; Ahmad M Mansour; Kevin L Winthrop; William L Hills; Justine R Smith
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-05-22

2.  Extrapulmonary Tuberculosis Presenting With Isolated Uveitis.

Authors:  Ali Mahdavi Fard; Rana Sorkhabi; Arezou Tajlil
Journal:  Iran J Public Health       Date:  2015-12       Impact factor: 1.429

Review 3.  Paradoxical reactions in ocular tuberculosis.

Authors:  Sudha K Ganesh; Sharanya Abraham; Sridharan Sudharshan
Journal:  J Ophthalmic Inflamm Infect       Date:  2019-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.